...Cancer immunotherapy company Tactiva Therapeutics Inc. (Buffalo, N.Y.) announced Dec. 3 it raised $18 million in the first...
...round led by Chinese VC firm Panacea Ventures. VI Ventures and EFung Capital also participated. Tactiva...
...million in a 2016 seed round (see “Third Cell's the Charm” ). Tactiva Therapeutics Inc., Buffalo, N.Y. Mark Zipkin Tactiva Therapeutics Inc. Multiple...

...Cancer immunotherapy company Tactiva Therapeutics Inc. (Buffalo, N.Y.) announced Monday it raised $35 million in a tranched series...
...round led by Chinese VC firm Panacea Ventures. VI Ventures and EFung Capital also participated. Tactiva...
...in 2019, including a multiple myeloma (MM) trial and a basket trial in solid tumors. Tactiva...

...persist long enough to generate sufficient numbers of memory CD8+ cells to eliminate the tumor. Tactiva...
...T cells are transduced with one TCR, and the HSCs with a second TCR that Tactiva...
...tumor antigen, in Phase I testing. Neither Adaptimmune nor Kite responded to requests for comment. Tactiva...